Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, can regrow lost cellular “antennae” in key ...

Researchers are using an advanced brain imaging method called MEG to understand why Parkinson’s drug levodopa doesn’t work ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

A breakthrough brain scan shows Parkinson’s drugs can misfire in the brain, helping some patients less than others. The fix?

Federal programs that support people with brain injury, such as HEADS UP and the National Concussion Surveillance System, are ...

In a breakthrough study, scientists found that silencing a single overactive enzyme in the brain reversed early damage caused ...

Researchers at Simon Fraser University reveal how brain imaging techniques can explain the inconsistent effects of levodopa ...

Parkinson's disease is traditionally associated with neurological damage in the brain, brought on by a drastic drop in ...

A targeted drug therapy has shown potential to reverse cellular damage in Parkinson's disease by regenerating critical brain ...

Scientists have discovered that earwax may hold clues to early Parkinson's detection. Analyzing volatile organic compounds ...

A new study suggests Parkinson's disease may start in the kidneys. Researchers in China found abnormal protein clumps in the ...